XML 47 R28.htm IDEA: XBRL DOCUMENT
v3.25.4

Segment Information | 12 Months Ended
--- | ---
Dec. 31, 2025
Segment Reporting [Abstract] |
Segment Information | Segment Information The Company operates in four segments: (1) a Medicaid segment, (2) a Medicare segment, (3) a Commercial segment and (4) an Other segment. The Medicaid, Medicare and Commercial segments primarily represent the government-sponsored or subsidized programs under which the Company offers managed healthcare services. The Other segment includes the Company's pharmacy operations, vision and dental services, clinical healthcare, behavioral health, and centralized services, among others. The Company signed a definitive agreement to divest the remaining Magellan Health businesses in December 2025. Factors used in determining the reportable business segments include the nature of operating activities, the existence of separate senior management teams and the type of information presented to the Company's chief operating decision-maker (CODM) to evaluate all results of operations. The Company's CODM is its Chief Executive Officer. The Company's CODM focuses primarily on each segment's ability to generate sufficient revenues and manage expenses associated with health benefits and cost of services (including estimated costs incurred). As such, the CODM measures operating performance at the segment level based on gross margin, including evaluation of budget to actual variances, to determine the allocation of financial and capital resources for each segment. The Company does not report total assets by segment since this is not a metric used by the Company's CODM to allocate resources or evaluate segment performance. Segment information for the year ended December 31, 2025, is as follows ($ in millions):
|  | Medicaid |  | Medicare |  | Commercial |  | Other/Eliminations |  |  |  | Consolidated Total
Premium | $ | 90,137 |  |  | $ | 37,210 |  |  | $ | 42,001 |  |  | $ | 2,208 |  |  |  |  | $ | 171,556 |
Service | 101 |  |  | — |  |  | 2 |  |  | 2,922 |  |  |  |  | 3,025 |
Premium and service revenues | 90,238 |  |  | 37,210 |  |  | 42,003 |  |  | 5,130 |  |  |  |  | 174,581 |
Premium tax | 20,196 |  |  | — |  |  | — |  |  | — |  |  |  |  | 20,196 |
Total external revenues | 110,434 |  |  | 37,210 |  |  | 42,003 |  |  | 5,130 |  |  |  |  | 194,777 |
Internal revenues | — |  |  | — |  |  | — |  |  | 16,854 |  |  |  |  | 16,854 |
Eliminations | — |  |  | — |  |  | — |  |  | (16,854) |  |  |  |  | (16,854) |
Total revenues | $ | 110,434 |  |  | $ | 37,210 |  |  | $ | 42,003 |  |  | $ | 5,130 |  |  |  |  | $ | 194,777 |
Medical costs | $ | 84,450 |  |  | $ | 34,227 |  |  | $ | 36,902 |  |  | $ | 2,123 |  |  |  |  | $ | 157,702 |
Cost of services | 98 |  |  | — |  |  | — |  |  | 2,572 |  |  |  |  | 2,670 |
Other operating expenses (1) |  |  |  |  |  |  |  |  |  |  | 42,028 |
Other income (expense) (2) |  |  |  |  |  |  |  |  |  |  | 895 |
Loss before income tax expense |  |  |  |  |  |  |  |  |  |  | $ | (6,728) |
Segment gross margin (3) | $ | 5,690 |  |  | $ | 2,983 |  |  | $ | 5,101 |  |  | $ | 435 |  |  |  |  | $ | 14,209 |
(1) | Other operating expenses include selling, general and administrative expenses, depreciation, amortization, premium tax expense and impairment.
(2) | Other income (expense) includes investment and other income, debt extinguishment and interest expense.
(3) | Segment gross margin represents premium and service revenues less medical costs and cost of services.
Segment information for the year ended December 31, 2024, is as follows ($ in millions):
|  | Medicaid |  | Medicare |  | Commercial |  | Other/Eliminations |  |  |  | Consolidated Total
Premium | $ | 83,758 |  |  | $ | 23,032 |  |  | $ | 33,699 |  |  | $ | 1,814 |  |  |  |  | $ | 142,303 |
Service | 93 |  |  | — |  |  | 3 |  |  | 3,106 |  |  |  |  | 3,202 |
Premium and service revenues | 83,851 |  |  | 23,032 |  |  | 33,702 |  |  | 4,920 |  |  |  |  | 145,505 |
Premium tax | 17,566 |  |  | — |  |  | — |  |  | — |  |  |  |  | 17,566 |
Total external revenues | 101,417 |  |  | 23,032 |  |  | 33,702 |  |  | 4,920 |  |  |  |  | 163,071 |
Internal revenues | — |  |  | — |  |  | — |  |  | 16,879 |  |  |  |  | 16,879 |
Eliminations | — |  |  | — |  |  | — |  |  | (16,879) |  |  |  |  | (16,879) |
Total revenues | $ | 101,417 |  |  | $ | 23,032 |  |  | $ | 33,702 |  |  | $ | 4,920 |  |  |  |  | $ | 163,071 |
Medical costs | $ | 77,516 |  |  | $ | 20,437 |  |  | $ | 26,039 |  |  | $ | 1,715 |  |  |  |  | $ | 125,707 |
Cost of services | 89 |  |  | — |  |  | — |  |  | 2,640 |  |  |  |  | 2,729 |
Other operating expenses (1) |  |  |  |  |  |  |  |  |  |  | 31,460 |
Other income (expense) (2) |  |  |  |  |  |  |  |  |  |  | 1,082 |
Earnings before income tax expense |  |  |  |  |  |  |  |  |  |  | $ | 4,257 |
Segment gross margin (3) | $ | 6,246 |  |  | $ | 2,595 |  |  | $ | 7,663 |  |  | $ | 565 |  |  |  |  | $ | 17,069 |
(1) | Other operating expenses include selling, general and administrative expenses, depreciation, amortization, premium tax expense and impairment.
(2) | Other income (expense) includes investment and other income, debt extinguishment and interest expense.
(3) | Segment gross margin represents premium and service revenues less medical costs and cost of services.
Segment information for the year ended December 31, 2023, is as follows ($ in millions):
|  | Medicaid |  | Medicare |  | Commercial |  | Other/Eliminations |  |  |  | Consolidated Total
Premium | $ | 86,853 |  |  | $ | 22,261 |  |  | $ | 24,843 |  |  | $ | 1,679 |  |  |  |  | $ | 135,636 |
Service | 2 |  |  | — |  |  | 2 |  |  | 4,455 |  |  |  |  | 4,459 |
Premium and service revenues | 86,855 |  |  | 22,261 |  |  | 24,845 |  |  | 6,134 |  |  |  |  | 140,095 |
Premium tax | 13,904 |  |  | — |  |  | — |  |  | — |  |  |  |  | 13,904 |
Total external revenues | 100,759 |  |  | 22,261 |  |  | 24,845 |  |  | 6,134 |  |  |  |  | 153,999 |
Internal revenues | — |  |  | — |  |  | — |  |  | 16,735 |  |  |  |  | 16,735 |
Eliminations | — |  |  | — |  |  | — |  |  | (16,735) |  |  |  |  | (16,735) |
Total revenues | $ | 100,759 |  |  | $ | 22,261 |  |  | $ | 24,845 |  |  | $ | 6,134 |  |  |  |  | $ | 153,999 |
Medical costs | $ | 78,210 |  |  | $ | 19,394 |  |  | $ | 19,816 |  |  | $ | 1,474 |  |  |  |  | $ | 118,894 |
Cost of services | 4 |  |  | — |  |  | — |  |  | 3,560 |  |  |  |  | 3,564 |
Other operating expenses (1) |  |  |  |  |  |  |  |  |  |  | 28,611 |
Other income (expense) (2) |  |  |  |  |  |  |  |  |  |  | 668 |
Earnings before income tax expense |  |  |  |  |  |  |  |  |  |  | $ | 3,598 |
Segment gross margin (3) | $ | 8,641 |  |  | $ | 2,867 |  |  | $ | 5,029 |  |  | $ | 1,100 |  |  |  |  | $ | 17,637 |
(1) | Other operating expenses include selling, general and administrative expenses, depreciation, amortization, premium tax expense and impairment.
(2) | Other income (expense) includes investment and other income, debt extinguishment and interest expense.
(3) | Segment gross margin represents premium and service revenues less medical costs and cost of services.

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-21 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 31 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-31 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-15 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 42 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-42 Reference 7: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 48 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-48 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 270 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482964/270-10-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (ee) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 11: http://fasb.org/us-gaap/role/ref/otherTransitionRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 32 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-32 Reference 12: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 13: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 14: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 15: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 16: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 54 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-54 Reference 17: http://www.xbrl.org/2003/role/exampleRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 47 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482785/280-10-55-47 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 22 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-22 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 34 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-34 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26C Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26B Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/280/tableOfContent Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 26 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-26 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 280 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 41 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-41 + Details
Name: | us-gaap_SegmentReportingDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration